Source:http://linkedlifedata.com/resource/pubmed/id/19596858
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
42
|
pubmed:dateCreated |
2009-10-12
|
pubmed:abstractText |
The amyloid precursor protein (APP) plays a central role in Alzheimer disease (AD) pathogenesis because sequential cleavages by beta- and gamma-secretase lead to the generation of the amyloid-beta (Abeta) peptide, a key constituent in the amyloid plaques present in brains of AD individuals. In several studies APP has recently been shown to form homodimers, and this event appears to influence Abeta generation. However, these studies have relied on APP mutations within the Abeta sequence itself that may affect APP processing by interfering with secretase cleavages independent of dimerization. Therefore, the impact of APP dimerization on Abeta production remains unclear. To address this question, we compared the approach of constitutive cysteine-induced APP dimerization with a regulatable dimerization system that does not require the introduction of mutations within the Abeta sequence. To this end we generated an APP chimeric molecule by fusing a domain of the FK506-binding protein (FKBP) to the C terminus of APP. The addition of the synthetic membrane-permeant drug AP20187 induces rapid dimerization of the APP-FKBP chimera. Using this system we were able to induce up to 70% APP dimers. Our results showed that controlled homodimerization of APP-FKBP leads to a 50% reduction in total Abeta levels in transfected N2a cells. Similar results were obtained with the direct precursor of beta-secretase cleavage, C99/SPA4CT-FKBP. Furthermore, there was no modulation of different Abeta peptide species after APP dimerization in this system. Taken together, our results suggest that APP dimerization can directly affect gamma-secretase processing and that dimerization is not required for Abeta production.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1083-351X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
16
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
28943-52
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19596858-Alzheimer Disease,
pubmed-meshheading:19596858-Amyloid beta-Peptides,
pubmed-meshheading:19596858-Amyloid beta-Protein Precursor,
pubmed-meshheading:19596858-Animals,
pubmed-meshheading:19596858-Catalytic Domain,
pubmed-meshheading:19596858-Cell Line, Tumor,
pubmed-meshheading:19596858-Dimerization,
pubmed-meshheading:19596858-Gene Expression Regulation,
pubmed-meshheading:19596858-Humans,
pubmed-meshheading:19596858-Mice,
pubmed-meshheading:19596858-Models, Biological,
pubmed-meshheading:19596858-Mutagenesis, Site-Directed,
pubmed-meshheading:19596858-Mutation,
pubmed-meshheading:19596858-Protein Structure, Tertiary,
pubmed-meshheading:19596858-Transfection
|
pubmed:year |
2009
|
pubmed:articleTitle |
Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production.
|
pubmed:affiliation |
Department of Neurosciences, University of California, San Diego, La Jolla, California 92093, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|